A feature article on efforts in Washington state to address the epidemic of prescription painkiller overdose deaths by LocalHealthGuide editor Michael McCarthy appears this week in the BMJ, the journal of the British Medical Society.
The group received 90 percent of its $5 million in funding in 2010 from the drug and medical-device industry, and its guides for patients, journalists and policymakers had played down the risks associated with opioid painkillers while exaggerating the benefits.
Higher U.S. spending for cancer care pays off in almost two years of additional life for American cancer patients on average compared to their European counterparts — a value that offsets our higher costs.
The Seattle Times series on methadone deaths highlights the drawbacks of drug treatment for pain and the need to explore alternative approaches, writes Bill Scott.
Following an series of articles in the Seattle Times drawing attention to the high death rate among patients taking methadone. Washington state will issue a public health advisory that singles out the unique risks of methadone, a commonly prescribed pain medicine that’s linked to the most accidental overdose deaths.
The Seattle Times has launched an investigative series on Washington state’s policy towards the use of the pain killer methadone for the treatment of chronic pain. The paper argues the drug is dangerously unpredictable and responsible for the deaths of hundreds, particularly among the poor.